+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2022 USA Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts - Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs

  • PDF Icon

    Report

  • April 2022
  • Region: United States
  • VPG Market Research
  • ID: 5575347
The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for
- HAV
- HBV
- NAT
- HBs
- Ag
- HCV
- Anti-HBc
- Anti-HBs
- Anti-HAV
- Hepatitis Delta
- HBc Ag
- HBe Ag, and
- ALT/SGPT tests performed in the following markets:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Labs ;     

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.